Literature DB >> 17475707

Ocular involvement in children with localised scleroderma: a multi-centre study.

Maria Elisabetta Zannin1, Giorgia Martini, Balu H Athreya, Ricardo Russo, Gloria Higgins, Fabio Vittadello, Maria Giannina Alpigiani, Mariolina Alessio, Mauro Paradisi, Patricia Woo, Francesco Zulian.   

Abstract

BACKGROUND: Most of the available documentation in the literature on ocular involvement in localised scleroderma (LS) are descriptions of single cases in adult patients. This article reports the frequency and specific features of ocular involvement in a large cohort of children with juvenile LS (JLS).
METHODS: Data from a large, multi-centre, multinational study of children with LS were used to collect and analyse specific information on ocular involvement.
RESULTS: 24 out of 750 patients (3.2%) revealed a significant ocular involvement. 16 were female and 8 male. 16 patients (66.7%) had scleroderma "en coup de sabre" (ECDS) of the face, 5 (20.8%) had the linear subtype, 2 (8.3%) had generalised morphea (GM) and one (4.2%) had plaque morphea (PM). Of the 24 patients with eye involvement, 10 patients (41.7%) reported adnexa (eyelids and eyelashes) abnormalities, 7 (29.2%) anterior segment inflammation (5 anterior uveitis, 2 episcleritis) and 3 central nervous system-related abnormalities. 4 patients presented single findings such as paralytic strabismus (1), pseudopapilloedema (1) and refractive errors (2). Other extracutaneous manifestations were detected in a significantly higher number of patients with ocular involvement and were mostly neurological.
CONCLUSION: Ocular abnormalities are not unusual in patients with JLS, especially in the ECDS subtype. They are frequently associated with other internal organ involvement, particularly the central nervous system (CNS). Careful ophthalmic monitoring is recommended for every patient with JLS, but is mandatory in those with skin lesions on the face and/or concomitant CNS involvement.

Entities:  

Mesh:

Year:  2007        PMID: 17475707      PMCID: PMC2001010          DOI: 10.1136/bjo.2007.116038

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  15 in total

1.  Linear scleroderma 'en coup de sabre' associated with cerebral and ocular vasculitis.

Authors:  A Holl-Wieden; T Klink; J Klink; M Warmuth-Metz; H J Girschick
Journal:  Scand J Rheumatol       Date:  2006 Sep-Oct       Impact factor: 3.641

2.  Linear scleroderma associated with ptosis and motility disorders.

Authors:  M S Suttorp-Schulten; L Koornneef
Journal:  Br J Ophthalmol       Date:  1990-11       Impact factor: 4.638

3.  Linear scleroderma. Report of a case presenting as persistent unilateral eyelid edema.

Authors:  P R Long; O F Miller
Journal:  J Am Acad Dermatol       Date:  1982-10       Impact factor: 11.527

4.  Ocular manifestations and treatment of hemifacial atrophy.

Authors:  R S Muchnick; S J Aston; T D Rees
Journal:  Am J Ophthalmol       Date:  1979-11       Impact factor: 5.258

Review 5.  Juvenile arthritis and uveitis.

Authors:  J J Kanski
Journal:  Surv Ophthalmol       Date:  1990 Jan-Feb       Impact factor: 6.048

Review 6.  Facial atrophy.

Authors:  T D Rees
Journal:  Clin Plast Surg       Date:  1976-10       Impact factor: 2.017

7.  Scleroderma en coup de sabre with central nervous system and ophthalmologic involvement: treatment of ocular symptoms with interferon gamma.

Authors:  Gerlinde Obermoser; Bettina E Pfausler; Dennis M Linder; Norbert T Sepp
Journal:  J Am Acad Dermatol       Date:  2003-09       Impact factor: 11.527

8.  Trigeminal sensory neuropathy. A study of 22 cases.

Authors:  B R Lecky; R A Hughes; N M Murray
Journal:  Brain       Date:  1987-12       Impact factor: 13.501

9.  Ocular involvement in scleroderma.

Authors:  R H West; A J Barnett
Journal:  Br J Ophthalmol       Date:  1979-12       Impact factor: 4.638

10.  A rare case of severe bilateral ectropion from scleroderma.

Authors:  J D Nancarrow; S M Jawad
Journal:  Plast Reconstr Surg       Date:  1981-03       Impact factor: 4.730

View more
  22 in total

1.  Ophthalmic findings in linear scleroderma manifesting as facial en coup de sabre.

Authors:  Hans Callø Fledelius; Patricia Louise Danielsen; Susanne Ullman
Journal:  Eye (Lond)       Date:  2018-07-04       Impact factor: 3.775

Review 2.  The central nervous system manifestations of localized craniofacial scleroderma: a study of 10 cases and literature review.

Authors:  Ezekiel Maloney; Sarah J Menashe; Ramesh S Iyer; Sarah Ringold; Amit K Chakraborty; Gisele E Ishak
Journal:  Pediatr Radiol       Date:  2018-07-03

Review 3.  Development of minimum standards of care for juvenile localized scleroderma.

Authors:  Tamás Constantin; Ivan Foeldvari; Clare E Pain; Annamária Pálinkás; Peter Höger; Monika Moll; Dana Nemkova; Lisa Weibel; Melinda Laczkovszki; Philip Clements; Kathryn S Torok
Journal:  Eur J Pediatr       Date:  2018-05-04       Impact factor: 3.183

4.  Linear scleroderma en coup de sabre in an adult female: Ocular, adnexal and tomographic features.

Authors:  Sushmita G Shah; Nirav D Raichura; Komal Parikh; Deepa Sonawane; Gaurav Y Shah
Journal:  Indian J Ophthalmol       Date:  2020-11       Impact factor: 1.848

Review 5.  Ocular complications of childhood rheumatic diseases: nonuveitic inflammatory eye diseases.

Authors:  Andreas Reiff
Journal:  Curr Rheumatol Rep       Date:  2009-07       Impact factor: 4.592

6.  The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures.

Authors:  Thaschawee Arkachaisri; Soamarat Vilaiyuk; Suzanne Li; Kathleen M O'Neil; Elena Pope; Gloria C Higgins; Marilynn Punaro; Egla C Rabinovich; Margalit Rosenkranz; Daniel A Kietz; Paul Rosen; Steven J Spalding; Teresa R Hennon; Kathryn S Torok; Elaine Cassidy; Thomas A Medsger
Journal:  J Rheumatol       Date:  2009-10-15       Impact factor: 4.666

Review 7.  [Scleroderma in childhood and adolescence. New aspects on classification, etiology and therapy].

Authors:  H J Girschick
Journal:  Z Rheumatol       Date:  2008-03       Impact factor: 1.372

Review 8.  Practice and Educational Gaps in Lupus, Dermatomyositis, and Morphea.

Authors:  Nicole M Fett; David Fiorentino; Victoria P Werth
Journal:  Dermatol Clin       Date:  2016-07       Impact factor: 3.478

Review 9.  Overview of Juvenile localized scleroderma and its management.

Authors:  Suzanne C Li; Rong-Jun Zheng
Journal:  World J Pediatr       Date:  2019-11-30       Impact factor: 2.764

Review 10.  Pediatric scleroderma: systemic or localized forms.

Authors:  Kathryn S Torok
Journal:  Pediatr Clin North Am       Date:  2012-04-06       Impact factor: 3.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.